EPM GROUP

epm Therapeutics is a biotechnology company developing synthetic cannabinoid acid derivatives. Our singular dedication is researching and developing the potential of our EPM301 to improve the symptoms of hyperphagia (uncontrolled appetite) in patients with PWS (Prader-Willi Syndrome) and improve their quality of life as well as that of their dedicated caregivers... epm was founded in 2017 by a group of entrepreneurs in collaboration with the Hebrew University in Jerusalem. Asaf Ohana, one of the group, suffered severe injuries during his time as an Israeli combat soldier and, over a period of five years, underwent extensive surgery and rehabilitation, during which he experienced the benefits of breakthrough CBD treatments, and became intrigued with their therapeutic potential... At epm Therapeutics, we strive for innovation. Thank you for your patience as we improve our website.

Also known as: epm, epm Group Inc, epm Therapeutics

Primary location: Florence United States